Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Adeera Levin, Marcello Tonelli, Joseph Bonventre, Josef Coresh, Jo-Ann Donner, Agnes Fogo, Caroline Fox, Ron Gansevoort, Hiddo Lambers Heerspink, Meg Jardine, Bertram Kasiske, Anna Kottgen, Matthias Kretzler, Andrew Levey, Valerie Luyckx, Ravindra Mehta, Gregorio Obrador, Orson Moe, Neesh Pannu, Chirag ParikhVlado Perkovic, Carol Pollock, Peter Stenvinkel, Katherine Tuttle, David Wheeler, Kai-Uwe Eckardt, Dwomoa Adu, Sanjay Agarwal, Mona Alrukhaimi, Hans-Joachim Anders, Gloria Ashuntantang, Shakti Basnet, Aminu Bello, Worawon Chailimpamontree, Ricardo Correa-Rotter, Jonathan Craig, Walter Douthat, H Feldman, Mohammad Ganji, Guillermo Garcia-Garcia, Mohammed Gharbi, David Harris, Vivekanand Jha, David Johnson, Rumeyza Kazancioglu, Robyn Langham, Zhi-hong Liu, Ziad Massy, Masaomi Nangaku, Robert Nelson, Donal O'Donoghue, Ikechi Okpechi, Roberto Pecoits-Filho, Neil Powe, Giuseppe Remuzzi, Charlotte Roberts, Jerome Rossert, Laura Sola, Benedicte Stengel, Ernest Sumaili, Yusuke Suzuki, Tetsuhiro Tanaka, Sajja Tatiyanupanwong, Bernadette Thomas, Katrin Uhlig, Robert Walker, Sarah White, Andrzej Wiecek, Chih-Wei Yang

Research output: Contribution to journalReview articlepeer-review

508 Citations (Scopus)


The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5–10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury—a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.

Original languageEnglish
Pages (from-to)1888-1917
Number of pages30
Issue number10105
Publication statusPublished - 21 Oct 2017


Dive into the research topics of 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy'. Together they form a unique fingerprint.

Cite this